All (n = 52) | MS (n = 25) | MT (n = 27) | p-value* | |
---|---|---|---|---|
Age | 66.6+/−12.1 | 60.8+/− 14.4 | 72+/−5.84 | 0.003 |
Gender | 0.462 | |||
Male | 37 (71) | 19 (76) | 18 (67) | |
Female | 15 (29) | 6 (24) | 9 (26) | |
Height (cm) | 170 ± 8.10 | 172 ± 8.3 | 168 ± 7.54 | 0.057 |
Weight (kg) | 78.6 ± 14.1 | 85.2 ± 12.4 | 72.5 ± 12.9 | 0.002 |
BSA (m2) | 1.90+/− 0.187 | 1.98+/− 0.167 | 1.83+/− 0.178 | 0.006 |
Hypertension,n (%) | 41 (79) | 16 (64) | 25 (92,5) | 0.013 |
Diabetes, n (%) | 11 (21,1) | 4 (16) | 7 (25,9) | 0.393 |
Creatinin (mg/dL) | ||||
baseline | 84.1+/− 23.6 | 83.7+/−14.7 | 84.6+/−21 | 0.533 |
GFR, ml/min | 76.5+/− 14.4 | 80+/− 14.7 | 73.2+/−13.6 | 0.036 |
Euroscore | 1.19+/−0.742 | 1.12+/− 0.734 | 1.26+/− 0.757 | 0.350 |
Echocardiography | ||||
AVA (cm2) | 0.772+/−0.138 | 0.8+/−0.131 | 0.74+/− 0.139 | 0.083 |
Mean gradient on | 49+/−12.5 | 49.3+/− 12.5 | 48.6+/− 12.7 | 0.783 |
Aortic valve (mmHg) | ||||
AVA index (cm2/m2) | 0.408+/−0.0763 | 0.415+/− 0.0693 | 0.393+/− 0.0836 | 0.595 |
Ejection fraction (%) | 63.3+/−10.8 | 61.8+/−8.83 | 64.7+/− 12.4 | 0.271 |
Velocity time integral | 21.7+/−3.37 | 21.9+/−3.38 | 21.5+/−3.41 | 0.854 |
VTI in LVOT (cm) | ||||
Anesthesia | ||||
MAP mmHg-baseline | 99.5+/−17.1 | 104+/− 14 | 95.4+/− 18.8 | 0.124 |
Fentanyl (mg) | 0.522+/−0.227 | 0.548+/− 0.265 | 0.498+/− 0.187 | 0.777 |
Propofol (mg) | 115+/−45.2 | 132+/−50.58 | 98.889+/−33.205 | 0.012 |
Rocuronium bromide (mg) | 96.1+/−31.4 | 107.2+/− 37.807 | 85.741+/−19.54 | 0.028 |
Remifentanyl (mg) | 4.88+/−1.67 | 5.468+/−1.457 | 4.338+/− 1.691 | 0.014 |
Propofol (gr) | 1.36+/−0.521 | 1.487+/− 0.36 | 1.247+/− 0.620 | 0.004 |